Recommendations and guidelines for the treatment of pneumonia in Taiwan

Infectious Diseases Society of Taiwan;, Taiwan Society of Pulmonary and Critical Care Medicine,, Medical Foundation in Memory of Dr. Deh-Lin Cheng;, Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research and Education;, CY Lee's Research Foundation for Pediatric Infectious Diseases and Vaccines,, The 4th Guidelines Recommendations for Evidence-based Antimicrobial agents use in Taiwan (GREAT) working group

研究成果: Letter

1 引文 (Scopus)

摘要

Pneumonia is a leading cause of death worldwide, ranking third both globally and in Taiwan. This guideline was prepared by the 2017 Guidelines Recommendations for Evidence-based Antimicrobial agents use in Taiwan (GREAT) working group, formed under the auspices of the Infectious Diseases Society of Taiwan (IDST). A consensus meeting was held jointly by the IDST, Taiwan Society of Pulmonary and Critical Care Medicine (TSPCCM), the Medical Foundation in Memory of Dr. Deh-Lin Cheng, the Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research and Education and CY Lee's Research Foundation for Pediatric Infectious Diseases and Vaccines. The final guideline was endorsed by the IDST and TSPCCM. The major differences between this guideline and the 2007 version include the following: the use of GRADE methodology for the evaluation of available evidence whenever applicable, the specific inclusion of healthcare-associated pneumonia as a category due to the unique medical system in Taiwan and inclusion of recommendations for treatment of pediatric pneumonia. This guideline includes the epidemiology and recommendations of antimicrobial treatment of community-acquired pneumonia, hospital-acquired pneumonia, ventilator-associated pneumonia, healthcare-associated pneumonia in adults and pediatric pneumonia.

原文English
頁(從 - 到)172-199
頁數28
期刊Journal of Microbiology, Immunology and Infection
52
發行號1
DOIs
出版狀態Published - 2019 二月 1

指紋

Taiwan
Pneumonia
Guidelines
Communicable Diseases
Therapeutics
Critical Care
Pediatrics
Medicine
Delivery of Health Care
Ventilator-Associated Pneumonia
Lung
Anti-Infective Agents
Research
Cause of Death
Epidemiology
Vaccines
Education

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology and Microbiology(all)
  • Microbiology (medical)
  • Infectious Diseases

引用此文

Infectious Diseases Society of Taiwan;, Taiwan Society of Pulmonary and Critical Care Medicine,, Medical Foundation in Memory of Dr. Deh-Lin Cheng;, Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research and Education;, CY Lee's Research Foundation for Pediatric Infectious Diseases and Vaccines,, & The 4th Guidelines Recommendations for Evidence-based Antimicrobial agents use in Taiwan (GREAT) working group (2019). Recommendations and guidelines for the treatment of pneumonia in Taiwan. Journal of Microbiology, Immunology and Infection, 52(1), 172-199. https://doi.org/10.1016/j.jmii.2018.11.004
Infectious Diseases Society of Taiwan; ; Taiwan Society of Pulmonary and Critical Care Medicine, ; Medical Foundation in Memory of Dr. Deh-Lin Cheng; ; Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research and Education; ; CY Lee's Research Foundation for Pediatric Infectious Diseases and Vaccines, ; The 4th Guidelines Recommendations for Evidence-based Antimicrobial agents use in Taiwan (GREAT) working group. / Recommendations and guidelines for the treatment of pneumonia in Taiwan. 於: Journal of Microbiology, Immunology and Infection. 2019 ; 卷 52, 編號 1. 頁 172-199.
@article{483b719cae6b411fae34ccbedd31b5eb,
title = "Recommendations and guidelines for the treatment of pneumonia in Taiwan",
abstract = "Pneumonia is a leading cause of death worldwide, ranking third both globally and in Taiwan. This guideline was prepared by the 2017 Guidelines Recommendations for Evidence-based Antimicrobial agents use in Taiwan (GREAT) working group, formed under the auspices of the Infectious Diseases Society of Taiwan (IDST). A consensus meeting was held jointly by the IDST, Taiwan Society of Pulmonary and Critical Care Medicine (TSPCCM), the Medical Foundation in Memory of Dr. Deh-Lin Cheng, the Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research and Education and CY Lee's Research Foundation for Pediatric Infectious Diseases and Vaccines. The final guideline was endorsed by the IDST and TSPCCM. The major differences between this guideline and the 2007 version include the following: the use of GRADE methodology for the evaluation of available evidence whenever applicable, the specific inclusion of healthcare-associated pneumonia as a category due to the unique medical system in Taiwan and inclusion of recommendations for treatment of pediatric pneumonia. This guideline includes the epidemiology and recommendations of antimicrobial treatment of community-acquired pneumonia, hospital-acquired pneumonia, ventilator-associated pneumonia, healthcare-associated pneumonia in adults and pediatric pneumonia.",
author = "{Infectious Diseases Society of Taiwan;} and {Taiwan Society of Pulmonary and Critical Care Medicine,} and {Medical Foundation in Memory of Dr. Deh-Lin Cheng;} and {Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research and Education;} and {CY Lee's Research Foundation for Pediatric Infectious Diseases and Vaccines,} and {The 4th Guidelines Recommendations for Evidence-based Antimicrobial agents use in Taiwan (GREAT) working group} and Chou, {Chih Chen} and Ching-Fen Shen and Chen, {Su Jung} and Chen, {Hsien Meng} and Wang, {Yung Chih} and Chang, {Wei Shuo} and Chang, {Ya Ting} and Chen, {Wei Yu} and Huang, {Ching Ying} and Kuo, {Ching Chia} and Ming-Chi Li and Lin, {Jung Fu} and Lin, {Shih Ping} and Ting, {Shih Wen} and Weng, {Tzu Chieh} and Wu, {Ping Sheng} and Wu, {Un In} and Lin, {Pei Chin} and Lee, {Susan Shin Jung} and Chen, {Yao Shen} and Liu, {Yung Ching} and Chuang, {Yin Ching} and Yu, {Chong Jen} and Huang, {Li Ming} and Lin, {Meng Chih}",
year = "2019",
month = "2",
day = "1",
doi = "10.1016/j.jmii.2018.11.004",
language = "English",
volume = "52",
pages = "172--199",
journal = "Journal of Microbiology, Immunology and Infection",
issn = "1684-1182",
publisher = "Elsevier Taiwan LLC",
number = "1",

}

Infectious Diseases Society of Taiwan;, Taiwan Society of Pulmonary and Critical Care Medicine, Medical Foundation in Memory of Dr. Deh-Lin Cheng;, Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research and Education;, CY Lee's Research Foundation for Pediatric Infectious Diseases and Vaccines, & The 4th Guidelines Recommendations for Evidence-based Antimicrobial agents use in Taiwan (GREAT) working group 2019, 'Recommendations and guidelines for the treatment of pneumonia in Taiwan', Journal of Microbiology, Immunology and Infection, 卷 52, 編號 1, 頁 172-199. https://doi.org/10.1016/j.jmii.2018.11.004

Recommendations and guidelines for the treatment of pneumonia in Taiwan. / Infectious Diseases Society of Taiwan; Taiwan Society of Pulmonary and Critical Care Medicine,; Medical Foundation in Memory of Dr. Deh-Lin Cheng; Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research and Education; CY Lee's Research Foundation for Pediatric Infectious Diseases and Vaccines,; The 4th Guidelines Recommendations for Evidence-based Antimicrobial agents use in Taiwan (GREAT) working group.

於: Journal of Microbiology, Immunology and Infection, 卷 52, 編號 1, 01.02.2019, p. 172-199.

研究成果: Letter

TY - JOUR

T1 - Recommendations and guidelines for the treatment of pneumonia in Taiwan

AU - Infectious Diseases Society of Taiwan;

AU - Taiwan Society of Pulmonary and Critical Care Medicine,

AU - Medical Foundation in Memory of Dr. Deh-Lin Cheng;

AU - Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research and Education;

AU - CY Lee's Research Foundation for Pediatric Infectious Diseases and Vaccines,

AU - The 4th Guidelines Recommendations for Evidence-based Antimicrobial agents use in Taiwan (GREAT) working group

AU - Chou, Chih Chen

AU - Shen, Ching-Fen

AU - Chen, Su Jung

AU - Chen, Hsien Meng

AU - Wang, Yung Chih

AU - Chang, Wei Shuo

AU - Chang, Ya Ting

AU - Chen, Wei Yu

AU - Huang, Ching Ying

AU - Kuo, Ching Chia

AU - Li, Ming-Chi

AU - Lin, Jung Fu

AU - Lin, Shih Ping

AU - Ting, Shih Wen

AU - Weng, Tzu Chieh

AU - Wu, Ping Sheng

AU - Wu, Un In

AU - Lin, Pei Chin

AU - Lee, Susan Shin Jung

AU - Chen, Yao Shen

AU - Liu, Yung Ching

AU - Chuang, Yin Ching

AU - Yu, Chong Jen

AU - Huang, Li Ming

AU - Lin, Meng Chih

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Pneumonia is a leading cause of death worldwide, ranking third both globally and in Taiwan. This guideline was prepared by the 2017 Guidelines Recommendations for Evidence-based Antimicrobial agents use in Taiwan (GREAT) working group, formed under the auspices of the Infectious Diseases Society of Taiwan (IDST). A consensus meeting was held jointly by the IDST, Taiwan Society of Pulmonary and Critical Care Medicine (TSPCCM), the Medical Foundation in Memory of Dr. Deh-Lin Cheng, the Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research and Education and CY Lee's Research Foundation for Pediatric Infectious Diseases and Vaccines. The final guideline was endorsed by the IDST and TSPCCM. The major differences between this guideline and the 2007 version include the following: the use of GRADE methodology for the evaluation of available evidence whenever applicable, the specific inclusion of healthcare-associated pneumonia as a category due to the unique medical system in Taiwan and inclusion of recommendations for treatment of pediatric pneumonia. This guideline includes the epidemiology and recommendations of antimicrobial treatment of community-acquired pneumonia, hospital-acquired pneumonia, ventilator-associated pneumonia, healthcare-associated pneumonia in adults and pediatric pneumonia.

AB - Pneumonia is a leading cause of death worldwide, ranking third both globally and in Taiwan. This guideline was prepared by the 2017 Guidelines Recommendations for Evidence-based Antimicrobial agents use in Taiwan (GREAT) working group, formed under the auspices of the Infectious Diseases Society of Taiwan (IDST). A consensus meeting was held jointly by the IDST, Taiwan Society of Pulmonary and Critical Care Medicine (TSPCCM), the Medical Foundation in Memory of Dr. Deh-Lin Cheng, the Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research and Education and CY Lee's Research Foundation for Pediatric Infectious Diseases and Vaccines. The final guideline was endorsed by the IDST and TSPCCM. The major differences between this guideline and the 2007 version include the following: the use of GRADE methodology for the evaluation of available evidence whenever applicable, the specific inclusion of healthcare-associated pneumonia as a category due to the unique medical system in Taiwan and inclusion of recommendations for treatment of pediatric pneumonia. This guideline includes the epidemiology and recommendations of antimicrobial treatment of community-acquired pneumonia, hospital-acquired pneumonia, ventilator-associated pneumonia, healthcare-associated pneumonia in adults and pediatric pneumonia.

UR - http://www.scopus.com/inward/record.url?scp=85059437821&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059437821&partnerID=8YFLogxK

U2 - 10.1016/j.jmii.2018.11.004

DO - 10.1016/j.jmii.2018.11.004

M3 - Letter

C2 - 30612923

AN - SCOPUS:85059437821

VL - 52

SP - 172

EP - 199

JO - Journal of Microbiology, Immunology and Infection

JF - Journal of Microbiology, Immunology and Infection

SN - 1684-1182

IS - 1

ER -

Infectious Diseases Society of Taiwan;, Taiwan Society of Pulmonary and Critical Care Medicine, Medical Foundation in Memory of Dr. Deh-Lin Cheng;, Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research and Education;, CY Lee's Research Foundation for Pediatric Infectious Diseases and Vaccines, The 4th Guidelines Recommendations for Evidence-based Antimicrobial agents use in Taiwan (GREAT) working group. Recommendations and guidelines for the treatment of pneumonia in Taiwan. Journal of Microbiology, Immunology and Infection. 2019 2月 1;52(1):172-199. https://doi.org/10.1016/j.jmii.2018.11.004